Find out about our current clinical studies, which are trying to understand the underlying mechanisms of disease and potential treatments for various inflammatory diseases including COVID-19 Current trials associated with the Centre are listed below. Trials run directly from the Centre are highlighted in blue, with trials run by external organisations in white. GuARDS Trial A UK-wide clinical trial involving 65 hospitals, exploring dexamethasone treatment in patients with acute respiratory distress syndrome (ARDS). TRAITS - Time Critical Precision Medicine programme TRAITS is a precision medicine research programme in critically ill adults. STOPCOVID A rapid interception experimental medicine programme for COVID-19 respiratory failure, spearheaded by the Centre for Inflammation Research in the Queen's Medical Research Institute at the Edinburgh BioQuarter. Crohn's and colitis trials CIR clinical trials for the discovery of new treatments and targets for Inflammatory Bowel Diseases (IBD) including Crohn's disease and ulcerative colitis. Endometriosis trials Endometriosis trials are led by the Centre for Excellence in Pelvic Pain and Endometriosis Care and Treatment (EXPPECT), which draws on expertise from CIR and the Centre for Reproductive Health (CRH). Further contributions to clinical trialsSPIRIT-PathThe SPIRIT-Path project aims to improve clinical trials involving pathology samples by developing International Guidance on the Inclusion of Pathology in Clinical Trial Protocols. It aims to create transparent, systematic methods to improve the quality and consistency of pathology-based research. Dr Tim Kendall is co-Chair of this study.Learn more about SPIRIT-Path Trial managementOur clinical trials are managed through the Academic and Clinical Central Office for Research and Development (ACCORD), a partnership between the University of Edinburgh and NHS Lothian Health Board.Visit the ACCORD website This article was published on 2024-09-10
